Literature DB >> 9059870

Salivary duct carcinoma: clinical characteristics and treatment strategies.

M Guzzo1, S Di Palma, C Grandi, R Molinari.   

Abstract

BACKGROUND: Salivary duct carcinoma (SDC) is a highly malignant tumor of the salivary gland.
METHODS: Twenty-six cases observed during the period 1975 to 1994 were selected from the pathology archives of the Instituto Nazionale Tumori of Milan. A review of all the similar cases published in the literature and comparison with the present series was performed.
RESULTS: SDC was mainly a parotid gland tumor diagnosed at an advanced stage. Lymphatic involvement seems to be related to T stage. Distant spread was evidently related to the presence of lymph node metastasis. Surgery with radiotherapy was the standard treatment. The only demonstrable negative prognostic factor was the presence of node metastases (p = 0.01).
CONCLUSIONS: Most patients died of disseminated disease in spite of an aggressive and often successful local-regional treatment. The role of a prophylactic ipsilateral neck dissection and adjunctive systemic treatment should be investigated.

Entities:  

Mesh:

Year:  1997        PMID: 9059870     DOI: 10.1002/(sici)1097-0347(199703)19:2<126::aid-hed7>3.0.co;2-6

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  36 in total

1.  Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Authors:  Young Cheol Weon; Sun-Won Park; Hyung-Jin Kim; Han-Sin Jeong; Young-Hyeh Ko; In Suh Park; Sung Tae Kim; Chung Hwan Baek; Young-Ik Son
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

2.  Prognostic relevance of cell proliferation in major salivary gland carcinomas.

Authors:  M Vacchi Suzzi; A Alessi; C Bertarelli; A Cancellieri; L Procaccio; D Dall'olio; P Laudadio
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

3.  [Ductal carcinoma of the parotid gland with the clinical picture of obstructive sialadenitis].

Authors:  F Hengstermann; M Tisch; K Kraft; H Maier
Journal:  HNO       Date:  2005-09       Impact factor: 1.284

Review 4.  Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Authors:  Roderick H W Simpson
Journal:  Head Neck Pathol       Date:  2013-07-03

5.  Salivary duct carcinoma: A clinopathological report of 11 cases.

Authors:  Xiaofeng Huang; Jing Hao; Sheng Chen; Runzhi Deng
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

6.  Salivary Duct Carcinoma of Parotid Gland: a Rare Tumor.

Authors:  Giridhar Chidananda-Murthy; Jayanthi Chandran
Journal:  Indian J Surg Oncol       Date:  2018-12-12

7.  Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; Sankar N Maity; Yu-Chen Lee; Renata Ferrarotto; Julian C Post; Lisa Licitra; Scott M Lippman; Merrill S Kies; Randal S Weber; Carlos Caulin; Sue-Hwa Lin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

8.  Management and outcome of salivary duct carcinoma in major salivary glands.

Authors:  Elina Salovaara; Olli Hakala; Leif Bäck; Petri Koivunen; Kauko Saarilahti; Fabricio Passador-Santos; Ilmo Leivo; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-22       Impact factor: 2.503

9.  Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.

Authors:  Tatsuo Masubuchi; Yuichiro Tada; Shin-ichiro Maruya; Yoshiyuki Osamura; Shin-etsu Kamata; Kouki Miura; Chihiro Fushimi; Hideaki Takahashi; Daisuke Kawakita; Seiji Kishimoto; Toshitaka Nagao
Journal:  Int J Clin Oncol       Date:  2014-02-20       Impact factor: 3.402

10.  Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.

Authors:  Vijayvel Jayaprakash; Mihai Merzianu; Graham W Warren; Hassan Arshad; Wesley L Hicks; Nestor R Rigual; Maureen A Sullivan; Mukund Seshadri; James R Marshall; David M Cohan; Yujie Zhao; Anurag K Singh
Journal:  Head Neck       Date:  2013-10-07       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.